Clinical Trials Browser

Phase 2 × Withdrawn × pamiparib × Clear all

NCT04603365 2023-05-17

Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

Phase 2 Withdrawn

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell

NCT04796454 2022-06-01

PAMICC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT03933761 2021-08-10

PRECISE

Phase 2 Withdrawn

GynecologicSarcoma

Carcinosarcoma, Ovarian Neoplasms